miR-494 plays a tumor-suppressive role in pancreatic cancer and inhibits EMT invasion and migration of cancerous cells via TGF-β/SMAD and hepatocyte growth factor (HGF)/MET signaling pathways. Here, HGF is linked to pancreatic neoplasm.